COVID-19 RNA May Be Linked to Metastatic Cancer Regression
When RNA from COVID-19 is released into the bloodstream, it activates a certain white blood cell, which becomes cancer-fighting cells, ...
Tag: melanoma
Longer Time Until Recurrence Associated With Better Melanoma Outcomes
Receiving postsurgical treatment with immunotherapy may lengthen the time until relapse.Among patients with advanced melanoma, a longer time until disease ...
Oncology Drugs Approved by the FDA in September 2024
List of oncology drugs approved by the FDA in September 2024.Throughout the month of September, several cancer therapies were approved ...
Long-Term Study Data Support Keytruda as Standard of Care for Advanced Melanoma
Keytruda (pembrolizumab) continued to improve survival versus Yervoy (ipilimumab) in patients with unresectable stage 3 or 4 melanoma, as demonstrated ...
Survival Benefit Continues at 10 Years From Opdivo Either Alone or With Yervoy in Advanced Melanoma
Among patients with advanced melanoma, treatment with Opdivo (nivolumab) with or without Yervoy (ipilimumab) benefited both overall survival (OS, the ...
FDA Approves Subcutaneous Tecentriq Formulation
FDA Approves Subcutaneous Tecentriq FormulationThe Food and Drug Administration (FDA) approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), a subcutaneous injection, for ...
FDA to Speed Up Review of IBI363 for Advanced Melanoma
The FDA is set to speed up the review for IBI363, a novel treatment for patients with locally advanced or ...
Immunotherapy Combination Elicit Waves of Response in Advanced Melanoma
An algorithm has helped researchers determine a combination of immunotherapy that may work best for patients with advanced melanoma. Cyclone, ...
Postsurgical Keytruda Has Little Impact on Quality of Life in Melanoma
Keytruda had little impact on longterm health-related quality of life for certain patients with melanoma, research showed. Receiving Keytruda (pembrolizumab) ...
Cancer Vaccine for NSCLC and Melanoma Could Be Paradigm-Changing
The phase 1 study evaluating this cancer vaccine is expected to be completed in June 2025. Some patients with skin ...
Presurgical Targeted Therapy, Immunotherapy Show Responses in Melanoma
In stage 3 melanoma, receiving targeted therapy and immunotherapy before surgery has shown better treatment responses.Presurgical treatment with targeted therapy ...
Researchers Urge Caution of Immunotherapy in Older Patients with Melanoma
An expert told CURE® that immunotherapy may come with a wide range of unpredictable side effects.For patients with melanoma aged ...